Femasys FemBloc achieved certification under MDSAP

Femasys (FEMY) announced that its FemBloc permanent birth control system has achieved certification under the Medical Device Single Audit Program, MDSAP. The MDSAP certification positions the Company to accelerate regulatory and commercial execution across key global markets, including the United States, Canada, Japan, Australia, and Brazil. In the U.S., FDA recognition of MDSAP reflects a high level of quality system maturity and supports regulatory readiness as the Company advances its trial toward PMA submission.